• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过第二代抗病毒 shRNA 预测和阻断 HIV-1 逃逸。

Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs.

机构信息

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.

出版信息

Retrovirology. 2010 Jun 8;7:52. doi: 10.1186/1742-4690-7-52.

DOI:10.1186/1742-4690-7-52
PMID:20529316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2898777/
Abstract

BACKGROUND

RNA interference (RNAi) is an evolutionary conserved gene silencing mechanism that mediates the sequence-specific breakdown of target mRNAs. RNAi can be used to inhibit HIV-1 replication by targeting the viral RNA genome. However, the error-prone replication machinery of HIV-1 can generate RNAi-resistant variants with specific mutations in the target sequence. For durable inhibition of HIV-1 replication the emergence of such escape viruses must be controlled. Here we present a strategy that anticipates HIV-1 escape by designing 2nd generation short hairpin RNAs (shRNAs) that form a complete match with the viral escape sequences.

RESULTS

To block the two favorite viral escape routes observed when the HIV-1 integrase gene sequence is targeted, the original shRNA inhibitor was combined with two 2nd generation shRNAs in a single lentiviral expression vector. We demonstrate in long-term viral challenge experiments that the two dominant viral escape routes were effectively blocked. Eventually, virus breakthrough did however occur, but HIV-1 evolution was skewed and forced to use new escape routes.

CONCLUSION

These results demonstrate the power of the 2nd generation RNAi concept. Popular viral escape routes are blocked by the 2nd generation RNAi strategy. As a consequence viral evolution was skewed leading to new escape routes. These results are of importance for a deeper understanding of HIV-1 evolution under RNAi pressure.

摘要

背景

RNA 干扰(RNAi)是一种进化上保守的基因沉默机制,介导靶 mRNA 的序列特异性降解。RNAi 可以通过靶向病毒 RNA 基因组来抑制 HIV-1 的复制。然而,HIV-1 易错复制机制可以产生具有靶序列特定突变的 RNAi 抗性变体。为了持久抑制 HIV-1 的复制,必须控制此类逃逸病毒的出现。在这里,我们提出了一种通过设计与病毒逃逸序列完全匹配的第二代短发夹 RNA(shRNA)来预测 HIV-1 逃逸的策略。

结果

为了阻断靶向 HIV-1 整合酶基因序列时观察到的两种最受欢迎的病毒逃逸途径,我们将原始 shRNA 抑制剂与两个第二代 shRNA 组合在单个慢病毒表达载体中。我们在长期病毒挑战实验中证明,两种主要的病毒逃逸途径都被有效地阻断了。然而,最终还是发生了病毒突破,但 HIV-1 的进化被扭曲,被迫使用新的逃逸途径。

结论

这些结果证明了第二代 RNAi 概念的强大。第二代 RNAi 策略阻断了常见的病毒逃逸途径。因此,病毒进化被扭曲,导致新的逃逸途径。这些结果对于深入了解 HIV-1 在 RNAi 压力下的进化具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/e31f1b389625/1742-4690-7-52-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/af1aa5095564/1742-4690-7-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/9fc557e3bbfa/1742-4690-7-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/9a4d9e9fda25/1742-4690-7-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/219409156daa/1742-4690-7-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/f239e33157eb/1742-4690-7-52-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/40cb8c419388/1742-4690-7-52-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/e31f1b389625/1742-4690-7-52-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/af1aa5095564/1742-4690-7-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/9fc557e3bbfa/1742-4690-7-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/9a4d9e9fda25/1742-4690-7-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/219409156daa/1742-4690-7-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/f239e33157eb/1742-4690-7-52-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/40cb8c419388/1742-4690-7-52-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b6/2898777/e31f1b389625/1742-4690-7-52-7.jpg

相似文献

1
Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs.通过第二代抗病毒 shRNA 预测和阻断 HIV-1 逃逸。
Retrovirology. 2010 Jun 8;7:52. doi: 10.1186/1742-4690-7-52.
2
Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs.第二代短发夹 RNA 定向 HIV-1 蛋白酶抑制剂耐药性的进化。
Antimicrob Agents Chemother. 2012 Jan;56(1):479-86. doi: 10.1128/AAC.05491-11. Epub 2011 Nov 7.
3
RNA interference as a tool for exploring HIV-1 robustness.RNA 干扰作为一种探索 HIV-1 稳健性的工具。
J Mol Biol. 2011 Oct 14;413(1):84-96. doi: 10.1016/j.jmb.2011.08.035. Epub 2011 Aug 22.
4
Design of extended short hairpin RNAs for HIV-1 inhibition.用于抑制HIV-1的延长型短发夹RNA的设计
Nucleic Acids Res. 2007;35(17):5683-93. doi: 10.1093/nar/gkm596. Epub 2007 Aug 21.
5
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.利用RNA干扰沉默HIV-1:一种多短发夹RNA方法。
Mol Ther. 2006 Dec;14(6):883-92. doi: 10.1016/j.ymthe.2006.07.007. Epub 2006 Sep 7.
6
Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference.当保守的基因组序列被RNA干扰靶向时,1型人类免疫缺陷病毒的逃逸受到限制。
J Virol. 2008 Mar;82(6):2895-903. doi: 10.1128/JVI.02035-07. Epub 2007 Dec 12.
7
Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.组合 RNAi 靶向 HIV-1 使用扩展短发夹 RNA。
Mol Ther. 2009 Oct;17(10):1712-23. doi: 10.1038/mt.2009.176. Epub 2009 Aug 11.
8
Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.严格的测试鉴定出了高效且能防止逃逸的抗艾滋病毒短发夹RNA。
J Gene Med. 2009 Jun;11(6):459-67. doi: 10.1002/jgm.1329.
9
RNA interference targeted to the conserved dimerization initiation site (DIS) of HIV-1 restricts virus escape mutation.针对 HIV-1 保守二聚化起始位点 (DIS) 的 RNA 干扰限制了病毒逃逸突变。
J Biochem. 2009 Oct;146(4):481-9. doi: 10.1093/jb/mvp093. Epub 2009 Jun 24.
10
The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.RNAi 基因治疗艾滋病中未受保护 T 细胞的影响。
Mol Ther. 2014 Mar;22(3):596-606. doi: 10.1038/mt.2013.280. Epub 2013 Dec 12.

引用本文的文献

1
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).全面分析治疗 SARS-CoV-2 感染的药物:当前 COVID-19 疗法的机制见解(综述)。
Int J Mol Med. 2020 Aug;46(2):467-488. doi: 10.3892/ijmm.2020.4608. Epub 2020 May 18.
2
Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.新型RNA双链体通过染色质介导的转录沉默将HIV-1锁定在潜伏状态。
Mol Ther Nucleic Acids. 2015 Oct 27;4(10):e261. doi: 10.1038/mtna.2015.31.
3
Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

本文引用的文献

1
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition.用于多种shRNA表达和持久抑制HIV-1的慢病毒载体设计
Mol Ther. 2008 Mar;16(3):557-564. doi: 10.1038/sj.mt.6300382. Epub 2016 Dec 8.
2
Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.RNAi 中的错配识别分析可实现等位基因特异性 siRNAs 的合理设计。
Nucleic Acids Res. 2009 Dec;37(22):7560-9. doi: 10.1093/nar/gkp835.
3
Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.组合 RNAi 靶向 HIV-1 使用扩展短发夹 RNA。
转录后基因沉默、转录基因沉默与人类免疫缺陷病毒
World J Virol. 2015 Aug 12;4(3):219-44. doi: 10.5501/wjv.v4.i3.219.
4
RNA interference approaches for treatment of HIV-1 infection.用于治疗HIV-1感染的RNA干扰方法。
Genome Med. 2015 May 28;7(1):50. doi: 10.1186/s13073-015-0174-y. eCollection 2015.
5
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.HIV-1 基因多样性对组合 RNAi 基因为基础的基因治疗功效的影响。
Gene Ther. 2015 Jun;22(6):485-95. doi: 10.1038/gt.2015.11. Epub 2015 Feb 26.
6
Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.针对猫冠状病毒的联合小干扰RNA疗法可在体外延缓抗病毒耐药性的出现。
Vet Microbiol. 2015 Mar 23;176(1-2):10-8. doi: 10.1016/j.vetmic.2014.12.009. Epub 2014 Dec 19.
7
Multiplexing seven miRNA-Based shRNAs to suppress HIV replication.复用七种基于微小RNA的短发夹RNA以抑制HIV复制。
Mol Ther. 2015 Feb;23(2):310-20. doi: 10.1038/mt.2014.205. Epub 2014 Oct 31.
8
Selection of RNAi-based inhibitors for anti-HIV gene therapy.用于抗HIV基因治疗的基于RNA干扰的抑制剂的选择。
World J Virol. 2012 Jun 12;1(3):79-90. doi: 10.5501/wjv.v1.i3.79.
9
Unmasking the information encoded as structural motifs of viral RNA genomes: a potential antiviral target.揭示病毒 RNA 基因组结构基序所编码的信息:一个潜在的抗病毒靶点。
Rev Med Virol. 2013 Nov;23(6):340-54. doi: 10.1002/rmv.1756. Epub 2013 Aug 27.
10
Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.通过具有粘性桥的化学合成适体实现多重抗 HIV-1 siRNA 的体内功能递送。
Mol Ther. 2013 Jan;21(1):192-200. doi: 10.1038/mt.2012.226. Epub 2012 Nov 20.
Mol Ther. 2009 Oct;17(10):1712-23. doi: 10.1038/mt.2009.176. Epub 2009 Aug 11.
4
RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences.通过靶向部分互补的病毒序列,RNA干扰介导的HIV-1抑制作用。
Nucleic Acids Res. 2009 Oct;37(18):6194-204. doi: 10.1093/nar/gkp644. Epub 2009 Aug 5.
5
96 shRNAs designed for maximal coverage of HIV-1 variants.设计用于最大程度覆盖HIV-1变体的96种短发夹RNA。
Retrovirology. 2009 Jun 4;6:55. doi: 10.1186/1742-4690-6-55.
6
HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1.HIV-1反式激活因子RNA沉默抑制活性在不同生物界中保守,并可抵消HIV-1的翻译抑制作用。
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):605-10. doi: 10.1073/pnas.0806822106. Epub 2009 Jan 2.
7
Update of the Drug Resistance Mutations in HIV-1.人类免疫缺陷病毒1型耐药突变的更新
Top HIV Med. 2008 Dec;16(5):138-45.
8
Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs.用于多重抗HIV RNA异位表达的miR-106b簇的工程设计与优化。
Gene Ther. 2008 Dec;15(23):1536-49. doi: 10.1038/gt.2008.147. Epub 2008 Sep 18.
9
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.HIV-1耐药性突变:高效抗逆转录病毒治疗第二个十年的更新框架
AIDS Rev. 2008 Apr-Jun;10(2):67-84.
10
Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.表达的抗乙肝病毒初级微小RNA穿梭体在体外和体内均能有效抑制病毒复制。
Mol Ther. 2008 Jun;16(6):1105-12. doi: 10.1038/mt.2008.82. Epub 2008 Apr 22.